Your email has been successfully added to our mailing list.

×
-0.0499999999999999 -0.0499999999999999 -0.0499999999999999 -0.00314444444444442 0.00444444444444455 -0.00833333333333326 0.00999999999999998 0.0227777777777778
Stock impact report

Menlo Therapeutics Reports First Quarter 2018 Financial Results

MENLO THERAPEUTICS INC COMMON (MNLO) 
Last menlo therapeutics inc common earnings: 3/3 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.menlotherapeutics.com/investor-relations
Company Research Source: GlobeNewswire
REDWOOD CITY, Calif., May 09, 2018 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ:MNLO), a late-stage biopharmaceutical company focused on the development of serlopitant for the treatment of pruritus associated with various underlying dermatologic conditions and for refractory chronic cough, today announced financial results for the first quarter ended March 31, 2018 and provided an update on its clinical development programs.  “We continue to make progress on the serlopitant clinical development program. We have initiated the Phase 3 program in prurigo nodularis, our lead indication,” stated Steve Basta, Chief Executive Officer of Menlo Therapeutics.  “Our Phase 2 study in refractory chronic cough will complete enrollment this month, with data expected in the fourth quarter of this year, and the Phase 2 study in pruritus associated with psoriasis is over 60% enrolled, with data expected in late 2018 or early 2019.” First Quarter Business Highlights and Recent Developments I Show less Read more
Impact Snapshot
Event Time:
MNLO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for MNLO alerts
Opt-in for
MNLO alerts

from News Quantified
Opt-in for
MNLO alerts

from News Quantified